| Schedule of revenues disaggregated by category |
Revenues disaggregated by category were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2022 |
|
2021 |
|
Product sales: |
|
|
|
|
|
|
|
Gross product sales |
|
$ |
22,618 |
|
$ |
16,109 |
|
Discounts and allowances |
|
|
(6,421) |
|
|
(3,733) |
|
Total product sales, net |
|
|
16,197 |
|
|
12,376 |
|
Revenues from collaborations: |
|
|
|
|
|
|
|
License revenues |
|
|
208 |
|
|
64,618 |
|
Research and development services and others |
|
|
330 |
|
|
1,024 |
|
Total revenues from collaborations |
|
|
538 |
|
|
65,642 |
|
Government contract |
|
|
— |
|
|
3,000 |
|
Total revenues |
|
$ |
16,735 |
|
$ |
81,018 |
|
|
| Schedule of product revenue allowance and reserve categories |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chargebacks, |
|
Government |
|
|
|
|
|
|
Discounts and |
|
and Other |
|
|
|
|
|
|
Fees |
|
Rebates |
|
Returns |
|
Total |
Balance as of January 1, 2022 |
|
$ |
3,404 |
|
$ |
2,494 |
|
$ |
2,017 |
|
$ |
7,915 |
Provision related to current period sales |
|
|
4,345 |
|
|
1,397 |
|
|
378 |
|
|
6,120 |
Credit or payments made during the period |
|
|
(3,322) |
|
|
(1,227) |
|
|
(31) |
|
|
(4,580) |
Balance as of March 31, 2022 |
|
$ |
4,427 |
|
$ |
2,664 |
|
$ |
2,364 |
|
$ |
9,455 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chargebacks, |
|
Government |
|
|
|
|
|
|
|
|
Discounts and |
|
and Other |
|
|
|
|
|
|
|
|
Fees |
|
Rebates |
|
Returns |
|
Total |
Balance as of January 1, 2021 |
|
$ |
2,461 |
|
$ |
2,115 |
|
$ |
1,489 |
|
$ |
6,065 |
Provision related to current period sales |
|
|
1,952 |
|
|
1,146 |
|
|
201 |
|
|
3,299 |
Credit or payments made during the period |
|
|
(2,727) |
|
|
(988) |
|
|
(243) |
|
|
(3,958) |
Balance as of March 31, 2021 |
|
$ |
1,686 |
|
$ |
2,273 |
|
$ |
1,447 |
|
$ |
5,406 |
|